insights_auto
Why is ALC up 2.57%?
Dive Deeperchevron_right
ALC:NYSE
Alcon AG
$67.83
arrow_upward
+2.57%(+1.70) 1D
$67.84
arrow_upward
+0.01% (+0.0100)todayPre-market
Closed: Oct 20, 4:00:08 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$67.39
High
$67.91
Low
$67.10
Mkt. cap
28.01B
Avg. vol.
1.80M
Volume
607.00
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
Open
$67.39
High
$67.91
Low
$67.10
Mkt. cap
28.01B
Avg. vol.
1.80M
Volume
607.00
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
AD HOC NEWS
·
29 minutes ago
Alcon buys Neurotech for USD 550 million: Berenberg backs Alcon stock
AD HOC NEWS
·
3 hours ago
Alcon stock acquires Neurotech before the Xetra open today
Investing.com Canada
·
12 hours ago
Alcon acquires Neurotech for $550m to expand retina portfolio By Investing.com
Stock Traders Daily
·
13 hours ago
Precision Trading with Alcon Inc. (ALC) Risk Zones
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com